B

bluebird bio
D

BLUE

0.29490
USD
-0.01
(-2.09%)
Market Closed
Volume
0
EPS
-2
Div Yield
-
P/E
-0
Market Cap
57,185,116
OverviewSignalsIdeasNews
Related Instruments
    A
    AKRO
    -1.660
    (-5.58%)
    28.070 USD
    B
    BHVN
    -4.260
    (-8.76%)
    44.390 USD
    B
    BPMC
    -6.990
    (-7.31%)
    88.690 USD
    I
    ICPT
    0
    (0%)
    0.000000 USD
    M
    MRTX
    0
    (0%)
    0.000000 USD
    R
    RARE
    -2.865
    (-6.02%)
    44.745 USD
    S
    SRPT
    -4.470
    (-4.10%)
    104.600 USD
    X
    XLRN
    0
    (0%)
    0.000000 USD
    More
News

Title: bluebird bio

Sector: Healthcare
Industry: Biotechnology
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.